Individual Case Safety Reports
The FDA has established a dedicated web resource for the Individual Case Safety Report (ICSR) health and regulatory data standard.
The source indicates this standard focuses on health and regulatory data, which impacts manufacturers of biologics and professionals involved in safety reporting and regulatory data management.
The consolidation of ICSR resources suggests a continued FDA emphasis on standardized electronic safety reporting for biologics. Maintaining alignment with these standards is critical for ensuring technical compliance and avoiding submission rejections in post-market surveillance workflows. Regulatory teams should interpret this as a central point for tracking technical specifications related to safety data exchange.
Regulatory and pharmacovigilance teams should verify that their submission systems remain aligned with current ICSR data standards and monitor this dedicated page for future technical specification updates. Data managers should ensure internal safety databases are mapping correctly to the relevant regulatory standards.
This web page is dedicated to the health and regulatory data standard: Individual Case Safety Report
Open in openFDA / FDA.gov